153 related articles for article (PubMed ID: 22761893)
1. Myoferlin depletion in breast cancer cells promotes mesenchymal to epithelial shape change and stalls invasion.
Li R; Ackerman WE; Mihai C; Volakis LI; Ghadiali S; Kniss DA
PLoS One; 2012; 7(6):e39766. PubMed ID: 22761893
[TBL] [Abstract][Full Text] [Related]
2. Loss of myoferlin redirects breast cancer cell motility towards collective migration.
Volakis LI; Li R; Ackerman WE; Mihai C; Bechel M; Summerfield TL; Ahn CS; Powell HM; Zielinski R; Rosol TJ; Ghadiali SN; Kniss DA
PLoS One; 2014; 9(2):e86110. PubMed ID: 24586247
[TBL] [Abstract][Full Text] [Related]
3. Down-regulating Myoferlin inhibits the vasculogenic mimicry of melanoma via decreasing MMP-2 and inducing mesenchymal-to-epithelial transition.
Zhang W; Zhou P; Meng A; Zhang R; Zhou Y
J Cell Mol Med; 2018 Mar; 22(3):1743-1754. PubMed ID: 29164766
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic modeling of the effects of myoferlin on tumor cell invasion.
Eisenberg MC; Kim Y; Li R; Ackerman WE; Kniss DA; Friedman A
Proc Natl Acad Sci U S A; 2011 Dec; 108(50):20078-83. PubMed ID: 22135466
[TBL] [Abstract][Full Text] [Related]
5. Myoferlin depletion elevates focal adhesion kinase and paxillin phosphorylation and enhances cell-matrix adhesion in breast cancer cells.
Blackstone BN; Li R; Ackerman WE; Ghadiali SN; Powell HM; Kniss DA
Am J Physiol Cell Physiol; 2015 Apr; 308(8):C642-9. PubMed ID: 25631868
[TBL] [Abstract][Full Text] [Related]
6. Myoferlin, a Membrane Protein with Emerging Oncogenic Roles.
Dong Y; Kang H; Liu H; Wang J; Guo Q; Song C; Sun Y; Zhang Y; Zhang H; Zhang Z; Guan H; Fang Z; Li F
Biomed Res Int; 2019; 2019():7365913. PubMed ID: 31828126
[TBL] [Abstract][Full Text] [Related]
7. Myoferlin is a key regulator of EGFR activity in breast cancer.
Turtoi A; Blomme A; Bellahcène A; Gilles C; Hennequière V; Peixoto P; Bianchi E; Noel A; De Pauw E; Lifrange E; Delvenne P; Castronovo V
Cancer Res; 2013 Sep; 73(17):5438-48. PubMed ID: 23864327
[TBL] [Abstract][Full Text] [Related]
8. High expression of myoferlin is associated with poor outcome in oropharyngeal squamous cell carcinoma patients and is inversely associated with HPV-status.
Kumar B; Brown NV; Swanson BJ; Schmitt AC; Old M; Ozer E; Agrawal A; Schuller DE; Teknos TN; Kumar P
Oncotarget; 2016 Apr; 7(14):18665-77. PubMed ID: 26919244
[TBL] [Abstract][Full Text] [Related]
9. Myoferlin silencing inhibits VEGFR2-mediated proliferation of metastatic clear cell renal cell carcinoma.
An HJ; Song DH; Koh HM; Kim YM; Ko GH; Lee JH; Lee JS; Yang JW; Kim MH; Seo DH; Jang SM; Kim DC
Sci Rep; 2019 Sep; 9(1):12656. PubMed ID: 31477752
[TBL] [Abstract][Full Text] [Related]
10. Myoferlin regulates epithelial cancer cell plasticity and migration through autocrine TGF-β1 signaling.
Barnhouse VR; Weist JL; Shukla VC; Ghadiali SN; Kniss DA; Leight JL
Oncotarget; 2018 Apr; 9(27):19209-19222. PubMed ID: 29721195
[TBL] [Abstract][Full Text] [Related]
11. Expression of myoferlin in human airway epithelium and its role in cell adhesion and zonula occludens-1 expression.
Leung C; Shaheen F; Bernatchez P; Hackett TL
PLoS One; 2012; 7(7):e40478. PubMed ID: 22808170
[TBL] [Abstract][Full Text] [Related]
12. An Emerging Therapeutic Approach by Targeting Myoferlin (MYOF) for Malignant Tumors.
Gu H; Peng Y; Chen Y
Curr Top Med Chem; 2020; 20(17):1509-1515. PubMed ID: 32552653
[TBL] [Abstract][Full Text] [Related]
13. Quantitative proteomics identifies myoferlin as a novel regulator of A Disintegrin and Metalloproteinase 12 in HeLa cells.
Zhou Y; Xiong L; Zhang Y; Yu R; Jiang X; Xu G
J Proteomics; 2016 Oct; 148():94-104. PubMed ID: 27432471
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of Myoferlin Suppresses Migration and Invasion in Clear-Cell Renal-Cell Carcinoma.
Cox A; Zhao C; Tolkach Y; Nettersheim D; Schmidt D; Kristiansen G; Mueller SC; Ritter M; Hauser S; Ellinger J
Anticancer Res; 2020 Jun; 40(6):3119-3128. PubMed ID: 32487606
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Analysis of Myoferlin in Human Pancreatic Cancer via Bioinformatics.
Pi R; Chen Y; Du Y; Dong S
Biomed Res Int; 2021; 2021():2602322. PubMed ID: 34957301
[TBL] [Abstract][Full Text] [Related]
16. Loss of dysferlin or myoferlin results in differential defects in excitation-contraction coupling in mouse skeletal muscle.
Barefield DY; Sell JJ; Tahtah I; Kearns SD; McNally EM; Demonbreun AR
Sci Rep; 2021 Aug; 11(1):15865. PubMed ID: 34354129
[TBL] [Abstract][Full Text] [Related]
17. Myoferlin Regulates Wnt/β-Catenin Signaling-Mediated Skeletal Muscle Development by Stabilizing Dishevelled-2 Against Autophagy.
Han S; Cui C; He H; Shen X; Chen Y; Wang Y; Li D; Zhu Q; Yin H
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31623157
[TBL] [Abstract][Full Text] [Related]
18. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
[TBL] [Abstract][Full Text] [Related]
19. Establishment of oxaliplatin-resistant gastric cancer organoids: importance of myoferlin in the acquisition of oxaliplatin resistance.
Harada K; Sakamoto N; Ukai S; Yamamoto Y; Pham QT; Taniyama D; Honma R; Maruyama R; Takashima T; Ota H; Takemoto Y; Tanabe K; Ohdan H; Yasui W
Gastric Cancer; 2021 Nov; 24(6):1264-1277. PubMed ID: 34272617
[TBL] [Abstract][Full Text] [Related]
20. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]